Pharsight

BRILINTA PATENTS FACING OPPOSITIONS

BRILINTA facing oppositions at the European Patent Office (EPO)

Patent Number Title Applicants Legal Status Legal Status Date Oppositions Activity Alert
EP2056832B1 Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate Revoked Mar 01, 2022
WITTKOPP, ALEXANDER
HEXAL BIOTECH
GENERICS